Drug
S-adenosyl-L-methionine (SAMe)
S-adenosyl-L-methionine (SAMe) is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
1
33%
Ph phase_4
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Not yet recruiting1
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
not_yet_recruiting133%
active_not_recruiting133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
not_yet_recruitingphase_2
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
NCT07495995
completedphase_4
S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands
NCT05363020
active_not_recruitingnot_applicable
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
NCT06026865
Clinical Trials (3)
Showing 3 of 3 trials
NCT07495995Phase 2
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
NCT05363020Phase 4
S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands
NCT06026865Not Applicable
S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3